Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Peter Frinking"'
Autor:
Tim Segers, Catherine Botteron, Alexandre Helbert, Victor Jeannot, Emmanuel Gaud, Peter Frinking
Publikováno v:
Ultrasound in medicine and biology, 46(12), 3339-3352. Elsevier
Recent advances in the field of monodisperse microbubble synthesis by flow focusing allow for the production of foam-free, highly concentrated and monodisperse lipid-coated microbubble suspensions. It has been found that in vitro, such monodisperse u
Publikováno v:
Ultrasound in Medicine & Biology. 46:892-908
Initial reports from the 1960s describing the observations of ultrasound contrast enhancement by tiny gaseous bubbles during echocardiographic examinations prompted the development of the first ultrasound contrast agent in the 1980s. Current commerci
Autor:
Hessel Wijkstra, Marcel Arditi, Simona Turco, Massimo Mischi, R.R. Wildeboer, Jonathan R. Lindner, Peter Frinking
Publikováno v:
Ultrasound in Medicine and Biology. 46(3):518-543
Ultrasound contrast agents (UCAs) have opened up immense diagnostic possibilities by combined use of indicator dilution principles and dynamic contrast-enhanced ultrasound (DCE-US) imaging. UCAs are microbubbles encapsulated in a biocompatible shell.
Publikováno v:
Lab on a chip, 19(1). Royal Society of Chemistry
Monodisperse phospholipid-coated ultrasound contrast agent (UCA) microbubbles can be directly synthesized in a lab-on-a-chip flow-focusing device. However, high total lipid concentrations are required to minimize on-chip bubble coalescence. Here, we
Publikováno v:
Applied physics letters, 116(17):173701. American Institute of Physics
Monodisperse lipid-coated microbubbles are a promising avenue to unlock the full potential of ultrasound contrast agents for medical diagnosis and therapy. However, their formation by microfluidic flow-focusing is non-trivial. The lipid monolayer she
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f591b0809324e2a450c33932a819ec41
https://research.utwente.nl/en/publications/40c5349e-1e60-4054-9cbf-953264d7b60f
https://research.utwente.nl/en/publications/40c5349e-1e60-4054-9cbf-953264d7b60f
Autor:
R. Scott, Charles Jameson, Peter Frinking, Manit Arya, Peter Acher, Hashim U. Ahmed, Chris Brew Graves, Mark Emberton, Sidath H. Liyanage, Alex Freeman, Gabriel Constantinescu, Susan C. Charman, Sanjeev Madaan, Jan van der Meulen, Bina Shah, Alistair Grey, Navin Ramachandran
Publikováno v:
Contemporary Clinical Trials. 66:86-92
OBJECTIVE: To compare the proportion of clinically significant prostate cancers (PCa) found in lesions detected by multiparametric MRI (mpMRI) with that found in lesions detected by multiparametric ultrasound (mpUSS), in men at risk. PATIENTS AND MET
Publikováno v:
Soft matter, 14(47), 9550-9561. Royal Society of Chemistry
The acoustic response of phospholipid-coated microbubble ultrasound contrast agents (UCA) is dramatically affected by their stabilizing shell. The interfacial shell elasticity increases the resonance frequency, the shell viscosity increases damping,
Publikováno v:
Langmuir, 33(39), 10329-10339. American Chemical Society
Resonantly driven monodisperse phospholipid-coated microbubbles are expected to substantially increase the sensitivity and efficiency in contrast-enhanced ultrasound imaging and therapy. They can be produced in a microfluidic flow-focusing device, bu
Publikováno v:
Physics in medicine and biology, 62(6), 2449-2464. IOP Publishing Ltd.
Physics in Medicine and Biology, 62(6), 2449-2464. Institute of Physics
Physics in Medicine and Biology, 62(6), 2449-2464. Institute of Physics
Ultrasound molecular imaging (USMI) is an emerging technique to monitor diseases at the molecular level by the use of novel targeted ultrasound contrast agents (tUCA). These consist of microbubbles functionalized with targeting ligands with high-affi
Autor:
Emmanuel Gaud, Thierry Bettinger, Jean-Marc Hyvelin, Maria Costa, Alexandre Helbert, Peter Frinking, Philippe Bussat
Publikováno v:
Journal of Ultrasound in Medicine. 36:941-953
Objectives To compare physicochemical characteristics and in vitro and in vivo contrast-enhanced ultrasound imaging performance of 3 commercially available ultrasound contrast agents: SonoVue (Bracco Imaging SpA, Colleretto Giacosa, Italy; also marke